428
MARYAM MIRZAZADEH et al.
Spectral Data
4-(4-Bromobenzylidene)-3-phenylisoxazol-5-one (4c)
1
IR (KBr): 3100, 1745, 1613, 1545, 1488,1072 cm−1; H NMR (400 MHz, CDCl3): δ 7.46
(s, 1H, ArCH=), 7.61-7.53 (m, 5H, Ph-H), 7.64 (d, 2H, J = 8.4 Hz, ArH), 8.19 (d, 2H,
J = 8.4 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ 119.39, 127.15, 128.18, 128.74, 128.95,
129.39, 129.64, 130.87, 131.14, 131.65, 132.43, 133.38, 135.19, 151.09, 163.92, 168.00.
4-(4-Hydroxybenzylidene)-3-phenylisoxazol-5(4H)-one (4f)
IR (KBr): 3357, 3050, 1725, 1580, 1531, 1448, 1375, 1301, 1225 cm−1; 1H NMR (400 MHz,
DMSO-d6): δ 6.92 (d, 2H, J = 8.8, ArH), 7.56-7.65 (m, 6H, Ph-H, ArCH=), 8.41 (d, 2H,
J = 8.8, ArH), 11.12 (s, 1H, OH); 13C NMR (100 MHz, DMSO-d6): δ 113.22, 116.62,
124.89, 127.94, 129.30, 129.69, 131.27, 136.88, 138.52, 153.74, 164.76, 169.39.
4-(2-Methoxybenzylidene)-3-phenylisoxazol-5-one (4h)
1
IR (KBr): 3065, 1739, 1587, 1543, 1476, 1365, 1251, 1169 cm−1; H NMR (400 MHz,
CDCl3): δ 3.84 (s, 3H, OMe), 6.93 (d, 1H, J = 8.4 Hz, ArH ), 7.08 (t, 1H, J = 7.6 Hz, ArH),
7.24-7.28 (m, 1H, ArH), 7.53-7.6 (m, 5H, Ph-H), 8.25 (s, 1H, ArCH=), 8.85 (d, 1H, J = 8.0
Hz, ArH); 13C NMR (100 MHz, CDCl3): δ 55.93, 117.14, 119.70, 121.82, 127.72, 127.90,
128.55, 128.76, 129.19, 130.37, 130.93, 133.45, 136.56, 147.33, 160.05, 164.21, 168.58.
4-(Naphthalen-2-ylmethylene)-3-phenylisoxazol-5(4H)-one (4i)
1
IR (KBr): 3050, 1743, 1592, 1542, 1377, 1269, 1069 cm−1; H NMR (400 MHz, CDCl3):
δ 7.54-7.94 (m, 11H, Ph-H, ArH), 8.46 (dd, 1H, J = 8.6 Hz, J = 1.2 Hz, ArH), 8.80 (s, 1H,
ArCH=); 13C NMR (100 MHz, CDCl3): δ 118.54, 127.13, 127.50, 127.86, 128.28, 128.59,
128.74, 128.84, 128.88, 129.36, 129.72, 129.98, 130.21, 131.05, 132.75, 135.82, 137.11,
152.75, 164.19, 168.32.
4-(2,4-Dimethoxybenzylidene)-3-phenylisoxazol-5(4H)-one (4j)
IR (KBr): 3072, 1741, 1572, 1534, 1504, 1473, 1428, 1379, 1272, 1213,1083 cm−1; 1H NMR
(400 MHz, CDCl3): δ 3.80(s, 3H, OMe), 3.91 (s, 3H, OMe), 6.39 (d, 1H, J = 2.0 Hz, ArH),
6.64 (dd, 1H, J = 9.1 Hz, J = 2.0 Hz, ArH), 7.53-7.63 (m, 5H, Ph-H), 8.18 (s, 1H, ArCH=),
9.21 (d, 1H, J = 9.1 Hz, ArH); 13C NMR (100 MHz, CDCl3): δ 55.88, 55.99, 97.75, 105.99,
113.53, 115.67, 127.98, 128.20, 128.72, 128.85, 129.06, 130.63, 136.36, 146.15, 162.59,
164.68, 167.30, 169.64.
4-(2,4-Dihydroxybenzylidene)-3-phenylisoxazol-5(4H)-one(4k)
IR (KBr): 3339, 3095, 1726, 1625, 1581, 1537, 1476, 1391, 1317, 1242, 1190, 1092 cm−1;
1H NMR (400 MHz, DMSO-d6): δ 6.37 (d, 1H, J= 1.6 Hz, ArH), 6.37 (dd, 1H, J = 9.0 Hz,
J = 1.6 Hz, ArH), 7.59 (s, 5H, Ph-H), 8.05 (s, 1H, ArCH=), 9.04 (d, 1H, J = 9.0 Hz, ArH),
11.09 (s, 2H, OH); 13C NMR (100 MHz, DMSO-d6): δ 102.10, 109.80, 113.82, 128.46,
129.27, 129.62, 131.16, 136.01, 146.59, 164.06, 165.33, 167.74, 170.09.
3-Phenyl-4-(-3-phenylallylidene) isoxazol-5(4H)-one (4l)
IR (KBr): 3080, 1747, 1610, 1535,1493, 1445, 1392, 1175, 1098 cm−1; 1H NMR (400 MHz,
CDCl3): δ 7.30 (d, 1H, , J= 15.6 Hz, =CH) 7.40-7.46 (m, 3H, ArH, Ph-H), 7.50 (d, 1H, J= 12
Hz, ArCH=), 7.55-7.66 (m, 7H, ArH, Ph-H), 8.43 (dd, 1H, J= 15.6 Hz, J= 12 Hz, CH=); 13C
NMR (100 MHz, CDCl3): δ 116.53, 122.78, 127.53, 128.22, 128.60, 129.09, 129.24, 129.29,
131.01, 131.63, 131.71, 135.00, 148.40, 150.08, 151.41, 152.33, 162.29, 169.31.